Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Regeneron ushers in new era with inaugural gene therapy approval
The FDA today approved the company’s Otarmeni, the first gene therapy for a rare genetic form of hearing loss that affects about 50 newborns per year.
Darren Incorvaia
Apr 23, 2026 3:22pm
The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags in Week 2
Apr 24, 2026 4:10pm
Why Molecular Testing Is Key to Brain Cancer Diagnosis
Brought to you by
Jazz Pharmaceuticals
UPDATED: Roche Q1 earnings see hits and misses across key products
Apr 24, 2026 1:55pm
AbbVie, Grace Therapeutics receive manufacturing-related CRLs
Apr 24, 2026 11:37am
With EU backing, Sanofi gains long-awaited win for tolebrutinib
Apr 24, 2026 11:30am
More News
Daiichi delays annual report amid ‘rapidly changing’ conditions
Apr 24, 2026 10:40am
Travere’s launchpad positions Filspari for fast rollout: analyst
Apr 24, 2026 10:06am
Can Trump’s UK deal become a drug pricing model?
Apr 24, 2026 9:00am
Pfizer drafts Fernando Mendoza as face of its cancer campaign
Apr 24, 2026 8:58am
